U.S. drug agency proposes rules to rein in opioid manufacturing

WASHINGTON (Reuters) - The U.S. Drug Enforcement Administration on Tuesday unveiled plans to rein in the amount of opioids that can be manufactured by drugmakers in a given year in an effort to combat the deadly opioid epidemic in the United States.